Thermo Fisher Scientific Inc. launched the spectral-enabled Invitrogen Attune Xenith Flow Cytometer, allowing immunology and immuno-oncology researchers to automate and streamline workflows to obtain more detailed and accurate insights from critical cellular samples.
By leveraging Thermo Fisher’s legacy core acoustic focusing technology, this new solution offers improved time to results for scientists researching cellular behaviors and mechanisms and discovering targeted therapies. It enables both spectral unmixing and conventional flow cytometry, allowing researchers to tackle a broader range of applications with greater flexibility and sensitivity.
The Attune Xenith Flow Cytometer’s features include:
- High-speed acoustic technology: Accelerates sample analysis, significantly reducing processing times while maintaining exceptional sensitivity.
- Clog-resistant design: Reduces stoppages and sample waste, allowing labs to operate more reliably with minimal sample volume.
- Higher parametric analysis: Equipped with six lasers and 51 fluorescent detectors, enabling detailed and accurate insights from each sample.
- Longer uptime: Designed for extended operation without needing fluid changes, maximizing lab productivity. Built-in cameras, automated maintenance and remote diagnostics help ensure ease of use for researchers of all experience levels.
*For research use only. Not for use in diagnostic procedures.
